Invasive pneumococcal disease in children <5 years of age in rural Mozambique

被引:54
作者
Roca, A. [1 ]
Sigauque, B.
Quinto, Ll.
Mandomando, I.
Valles, X.
Espasa, M.
Abacassamo, F.
Sacarlal, J.
Macete, E.
Nhacolo, A.
Levine, M.
Alonso, P.
机构
[1] Univ Barcelona, Hosp Clin, IDIBAPS, Ctr Salut Int, Barcelona 08036, Spain
[2] Minist Saude, Ctr Invest Saude Manhica, Maputo, Mozambique
[3] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique
[4] Minist Saude, Direccao Nacl Saude, Maputo, Mozambique
[5] Univ Maryland, Sch Sci, Ctr Vaccine Dev, Baltimore, MD USA
关键词
Pneumococcus; invasive pneumococcal disease; incidence; clinical presentation; Africa;
D O I
10.1111/j.1365-3156.2006.01697.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES To estimate the incidence and epidemiological characteristics of invasive pneumococcal disease (IPD) in children < 5 years of age living in a rural area of southern Mozambique. METHODS As part of the clinical management of children admitted to Manhica District Hospital, prospective surveillance for invasive bacterial disease was conducted from June 2001 to May 2003. The level of antibiotic resistance of the isolates was also analysed. RESULTS Pneumococcus was the most commonly isolated bacterium, accounting for 212 episodes. The estimated crude incidence rate of IPD in the study area among children < 5 years of age was 416/100 000 per child-year at risk. The youngest age group (< 3 months) had the highest incidence (779/100 000). Cases were detected during both rainy and dry seasons. The most common clinical diagnosis was pneumonia, made in 146/212 (69%) of the episodes of IPD. The overall case fatality rate was 10%, being highest among children with pneumococcal meningitis (5/9 = 56%). Pneumococcal isolates were highly susceptible to penicillin (86% susceptible and 14% with intermediate resistance) and chloramphenicol (98% susceptible). In contrast, up to 37% of the isolates tested were non-susceptible to cotrimoxazole. CONCLUSIONS Incidence rates of IPD and associated mortality shown in this study highlight the need for pneumococcal vaccines in rural Africa, which must be effective in infants and young children.
引用
收藏
页码:1422 / 1431
页数:10
相关论文
共 38 条
[1]   Efficacy of chloroquine, amodiaquine, sulphadoxine- pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria [J].
Abacassamo, F ;
Enosse, S ;
Aponte, JJ ;
Gómez-Olivé, FX ;
Quintó, L ;
Mabunda, S ;
Barreto, A ;
Magnussen, P ;
Ronn, AM ;
Thompson, R ;
Alonso, PL .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (02) :200-208
[2]   Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial [J].
Alonso, PL ;
Sacarlal, J ;
Aponte, JJ ;
Leach, A ;
Macete, E ;
Milman, J ;
Mandomando, I ;
Spiessens, B ;
Guinovart, C ;
Espasa, M ;
Bassat, Q ;
Aide, P ;
Ofori-Anyinam, O ;
Navia, MM ;
Corachan, S ;
Ceuppens, M ;
Dubois, MC ;
Demoitié, MA ;
Dubovsky, F ;
Menéndez, C ;
Tornieporth, N ;
Ballou, WR ;
Thompson, R ;
Cohen, J .
LANCET, 2004, 364 (9443) :1411-1420
[3]   RANDOMIZED TRIAL OF EFFICACY OF SPF66 VACCINE AGAINST PLASMODIUM-FALCIPARUM MALARIA IN CHILDREN IN SOUTHERN TANZANIA [J].
ALONSO, PL ;
SMITH, T ;
SCHELLENBERG, JRMA ;
MASANJA, H ;
MWANKUSYE, S ;
URASSA, H ;
DEAZEVEDO, IB ;
CHONGELA, J ;
KOBERO, S ;
MENENDEZ, C ;
HURT, N ;
THOMAS, MC ;
LYIMO, E ;
WEISS, NA ;
HAYES, R ;
KITUA, AY ;
LOPEZ, MC ;
KILAMA, WL ;
TEUSCHER, T ;
TANNER, M .
LANCET, 1994, 344 (8931) :1175-1181
[4]  
ALONSO PL, 2002, POPULATION HLTH DEV, P89
[5]  
BARRETO A, 2004, IMPACTO DEMOGRAFICO, P1
[6]   Bacteremia among children admitted to a rural hospital in Kenya [J].
Berkley, JA ;
Lowe, BS ;
Mwangi, I ;
Williams, T ;
Bauni, E ;
Mwarumba, S ;
Ngetsa, C ;
Slack, MPE ;
Njenga, S ;
Hart, CA ;
Maitland, K ;
English, M ;
Marsh, K ;
Scott, JAG .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01) :39-47
[7]   Invasive pneumococcal infections among hospitalized children in Bamako, Mali [J].
Campbell, JD ;
Kotloff, KL ;
Sow, SO ;
Tapia, M ;
Keita, MM ;
Keita, T ;
Diallo, S ;
Hormazabal, JC ;
Murray, P ;
Levine, MM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (07) :642-649
[8]   Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controled trial [J].
Chintu, C ;
Bhat, GJ ;
Walker, AS ;
Mulenga, V ;
Sinyinza, F ;
Lishimpi, K ;
Farrelly, L ;
Kaganson, N ;
Zumla, A ;
Gillespie, SH ;
Nunn, AJ ;
Gibb, DM .
LANCET, 2004, 364 (9448) :1865-1871
[9]   Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial [J].
Cutts, FT ;
Zaman, SMA ;
Enwere, G ;
Jaffar, S ;
Levine, OS ;
Okoko, JB ;
Oluwalana, C ;
Vaughan, A ;
Obaro, SK ;
Leach, A ;
McAdam, KP ;
Biney, E ;
Saaka, M ;
Onwuchekwa, U ;
Yallop, F ;
Pierce, NF ;
Greenwood, BM ;
Adegbola, RA .
LANCET, 2005, 365 (9465) :1139-1146
[10]   Seasonal patterns of invasive pneumococcal disease [J].
Dowell, SF ;
Whitney, CG ;
Wright, C ;
Rose, CE ;
Schuchat, A .
EMERGING INFECTIOUS DISEASES, 2003, 9 (05) :573-579